Lifeline/ReviveR DDU-100, Lifeline/ReviveR AUTO DDU-120, Lifeline/ReviveR VIEW DDU-2300, Lifeline/ReviveR VIEW AUTO DDU-
Defibtech, LLC · Decision date Jul 24, 2026
What did the FDA approve?
FDA records P160032/S014 as a supplement to PMA P160032, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Jul 24, 2026.
FDA approval order statement
extending the Defibtech DDU-2000 series AED to the new VIEW 2 series which include models: Lifeline VIEW 2 model DDU-2950, Lifeline VIEW 2 AUTO DDU-2955, Lifeline ECG 2 DDU-2960, and the Universal Pads accessory model DDP-2004.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Jul 24, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P160032/S014
- Regulatory pathway
- PMA supplement
- Applicant
- Defibtech, LLC
- Product code
- MKJ
- Decision code
- APPR
- Decision date
- Jul 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- Defibtech, LLC
- Product code
- MKJ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P160032/S014 received
Application receipt date recorded by FDA.
P160032/S015 · Related supplement
Defibtech Lifeline; Defibtech Lifeline AUTO; Defibtech Lifeline VIEW; Defibtech Lifeline VIEW AUTO; Defibtech Lifeline E
P160032/S016 · Related supplement
Defibtech Automated External Defibrillator (AED) Systems
P160032/S014 · FDA decision
Normal 180 Day Track
P160032/S017 · Related supplement
Lifeline VIEW 2, Lifeline VIEW 2 AUTO and Lifeline ECG 2 AED
Timeline entries are records held by MedtechLedger for P160032. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160032
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Defibtech, LLC | PMA supplement | Jun 16, 2026 | FDA | |
| Defibtech, LLC | PMA supplement | Jun 25, 2026 | FDA | |
| Defibtech, LLC | PMA supplement | Aug 25, 2026 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA | |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Defibtech, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 741 Boston Post Rd., Suite 201, Guilford, CT, 06437
Sources and methodology
- Original FDA record: P160032/S014
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



